NASDAQ:IKNX IKONICS (IKNX) Stock Price, News & Analysis → Forget NVIDIA, buy this $2 AI stock now… (From Behind the Markets) (Ad) Free IKNX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$26.61▼$42.3152-Week Range N/AVolume1,394 shsAverage Volume136,576 shsMarket Capitalization$67.16 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get IKONICS alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About IKONICS Stock (NASDAQ:IKNX)IKONICS Corp. engages in the development, manufacture, and trade of photochemical imaging products. It operates through the following business segments: Chromaline, IKONICS Imaging, Digital Texturing (DTX) and Advanced Material Solutions (AMS). The Chromaline Segment sells screen printing film, emulsions, and inkjet receptive film primarily to distributors and some end users. The IKONICS Imaging segment develops and sells photo resistant film, art supplies, glass, metal medium, and abrasive etching equipment. The DTX segment includes patented inkjet technology used for mold texturing and prototyping. The AMS segment supplies sound deadening technology to the aerospace industry. The company was founded in 1952 and is headquartered in Duluth, MN.Read More Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> IKNX Stock News HeadlinesDecember 30, 2023 | finanznachrichten.deTerawulf Inc.: TeraWulf Reports Fully Funded 7.9 EH/s and Future Expansion PlansFebruary 12, 2023 | duluthnewstribune.comIkonics reports earnings drop for 2013April 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.January 27, 2023 | duluthnewstribune.comIkonics to sell technology to Japanese auto industryJanuary 18, 2023 | thestreet.com3 Stocks Pushing The Chemicals Industry LowerAugust 16, 2022 | finance.yahoo.comSAATI and IKONICS Sign Definitive Acquisition AgreementDecember 14, 2021 | finance.yahoo.comGwyneth Paltrow-Backed Bitcoin Miner TeraWulf Plunges in Trading DebutDecember 13, 2021 | finance.yahoo.comTeraWulf Inc. Launches as Publicly Traded Bitcoin Mining Company with a Fully Integrated, Environmentally Clean PlatformApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.November 15, 2021 | finance.yahoo.comTeraWulf Inc. and IKONICS Corporation Announce Effectiveness of Registration Statement and Special Meeting Date in Connection with Proposed Business CombinationOctober 28, 2021 | finance.yahoo.comIKONICS Announces Third Quarter 2021 ResultsOctober 1, 2021 | finance.yahoo.comBragar Eagel & Squire, P.C. Announces that it Is Investigating the Boards of Directors of IKONICS Corporation, Investors Bancorp, MGM Growth Properties, and Vine Energy on behalf of Stockholders and Encourages Investors to Contact the FirmSeptember 28, 2021 | finance.yahoo.comSHAREHOLDER ALERT: Halper Sadeh LLP Investigates ICBK, VNE, SVBI, IKNX; Shareholders are Encouraged to Contact the FirmAugust 30, 2021 | finance.yahoo.comLifshitz Law Firm, P.C. Announces Investigation of FMBI, IKNX, MSON, and VICIAugust 26, 2021 | finance.yahoo.comLifshitz Law Firm, P.C. Announces Investigation of FMBI, IKNX, INOV, and SAFMAugust 21, 2021 | finance.yahoo.comLifshitz Law Firm, P.C. Announces Investigation of CLDB, IKNX, INOV, SAFMAugust 6, 2021 | finance.yahoo.comIKONICS Announces Second Quarter 2021 ResultsAugust 5, 2021 | finance.yahoo.comINVESTIGATION ALERT: Halper Sadeh LLP Investigates SQ, TBIO, OSBC, IKNX; Shareholders are Encouraged to Contact the FirmAugust 4, 2021 | finance.yahoo.comLifshitz Law Firm, P.C. Announces Investigation of CLDB, FFWM, IKNX, and RBNCAugust 2, 2021 | finance.yahoo.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates RFL, LDL, MMAC, IKNX; Shareholders are Encouraged to Contact the FirmAugust 2, 2021 | apnews.comForm S-4 Filed in Connection with the Proposed Business Combination of Bitcoin Miner TeraWulf Inc. and IKONICS CorporationSee More Headlines Receive IKNX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IKONICS and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/25/2019Today4/19/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorIndustrials Industry Data Processing & Preparation Sub-IndustryN/A Current SymbolNASDAQ:IKNX CUSIPN/A CIK1083301 Webwww.ikonics.com Phone(218) 628-2217Fax218-628-3245Employees58Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.22) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-440,000.00 Net Margins-2.66% Pretax Margin-2.48% Return on Equity11.27% Return on Assets8.89% Debt Debt-to-Equity RatioN/A Current Ratio2.37 Quick Ratio1.62 Sales & Book Value Annual Sales$13.43 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow259.44 Book Value$5.99 per share Price / BookN/AMiscellaneous Outstanding Shares1,981,000Free Float1,689,000Market Cap$67.16 million OptionableNot Optionable Beta0.90 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesGlenn SandgrenChief Executive Officer & DirectorKenneth HegmanChief Operating OfficerJon R. GerlachChief Financial Officer, Secretary & VP-FinanceClaude P. PiguetExecutive Vice PresidentKey CompetitorsFreightCar AmericaNASDAQ:RAILAqua MetalsNASDAQ:AQMSShengfeng DevelopmentNASDAQ:SFWLDIRTT Environmental SolutionsNASDAQ:DRTTShimmickNASDAQ:SHIMView All Competitors IKNX Stock Analysis - Frequently Asked Questions How were IKONICS's earnings last quarter? IKONICS Co. (NASDAQ:IKNX) posted its quarterly earnings data on Thursday, April, 25th. The specialty chemicals company reported ($0.23) earnings per share (EPS) for the quarter. The specialty chemicals company had revenue of $3.53 million for the quarter. IKONICS had a positive trailing twelve-month return on equity of 11.27% and a negative net margin of 2.66%. What is Bill Ulland's approval rating as IKONICS's CEO? 3 employees have rated IKONICS Chief Executive Officer Bill Ulland on Glassdoor.com. Bill Ulland has an approval rating of 37% among the company's employees. This puts Bill Ulland in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of IKONICS own? Based on aggregate information from My MarketBeat watchlists, some companies that other IKONICS investors own include Consolidated Edison (ED), Marijuana Company of America (MCOA), First Solar (FSLR), LexinFintech (LX), AbbVie (ABBV), TD Ameritrade (AMTD), Algonquin Power & Utilities (AQN), BCE (BCE), Blackrock Resources & Commodities Strategy Trust (BCX) and Franklin Resources (BEN). This page (NASDAQ:IKNX) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchThe #1 Crypto for 2024InvestorPlaceYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IKONICS Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.